Cavernous angioma epidemiology and demographics

Cavernous angioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Cavernous angioma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
CT
MRI
MRA
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cavernous angioma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cavernous angioma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cavernous angioma epidemiology and demographics
CDC on Cavernous angioma epidemiology and demographics
Cavernous angioma epidemiology and demographics in the news
Blogs on Cavernous angioma epidemiology and demographics
Directions to Hospitals Treating Cavernous angioma
Risk calculators and risk factors for Cavernous angioma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

The incidence in the general population is between 0.1–0.5%, and clinical symptoms typically appear between 30 to 50 years of age. Once thought to be strictly congenital, these vascular lesions have been found to occur de novo.

Age

Cavernous malformations can occur at any age, but they are most likely to become clinically apparent in patients aged 20-40 years.